Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 8 | 2024 | 1776 | 1.400 |
Why?
|
| Pacemaker, Artificial | 2 | 2024 | 221 | 1.180 |
Why?
|
| Plasma Exchange | 2 | 2018 | 116 | 1.050 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 2024 | 241 | 1.010 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 509 | 1.000 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 800 | 0.950 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 42 | 0.910 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 69 | 0.840 |
Why?
|
| Heart Diseases | 3 | 2018 | 756 | 0.730 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 622 | 0.730 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.720 |
Why?
|
| Anticoagulants | 4 | 2022 | 858 | 0.710 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 24 | 0.710 |
Why?
|
| Electrocardiography | 4 | 2018 | 1227 | 0.700 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2024 | 135 | 0.700 |
Why?
|
| Factor Xa Inhibitors | 2 | 2018 | 79 | 0.630 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 433 | 0.630 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2018 | 269 | 0.620 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 56 | 0.610 |
Why?
|
| Exercise Therapy | 1 | 2020 | 293 | 0.580 |
Why?
|
| Hemorrhage | 2 | 2022 | 767 | 0.580 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 249 | 0.570 |
Why?
|
| Thromboembolism | 1 | 2018 | 160 | 0.570 |
Why?
|
| Fontan Procedure | 2 | 2020 | 178 | 0.540 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 522 | 0.510 |
Why?
|
| Stroke | 2 | 2022 | 1199 | 0.510 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 54 | 0.500 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 124 | 0.470 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 317 | 0.470 |
Why?
|
| Tachycardia, Supraventricular | 3 | 2022 | 103 | 0.470 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 322 | 0.460 |
Why?
|
| Electric Countershock | 1 | 2014 | 75 | 0.450 |
Why?
|
| Coronary Vessels | 1 | 2018 | 692 | 0.450 |
Why?
|
| Pyridones | 1 | 2015 | 366 | 0.420 |
Why?
|
| Administration, Oral | 3 | 2022 | 1583 | 0.380 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 201 | 0.380 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 77 | 0.370 |
Why?
|
| Survivors | 1 | 2016 | 1030 | 0.370 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 102 | 0.370 |
Why?
|
| Exercise | 1 | 2018 | 1220 | 0.360 |
Why?
|
| Heart Rate | 3 | 2024 | 752 | 0.350 |
Why?
|
| Cardiac Catheterization | 4 | 2023 | 761 | 0.290 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1286 | 0.280 |
Why?
|
| Pyrazoles | 1 | 2015 | 1523 | 0.280 |
Why?
|
| Mass Screening | 1 | 2013 | 1568 | 0.240 |
Why?
|
| Humans | 30 | 2024 | 270843 | 0.230 |
Why?
|
| Amiodarone | 1 | 2024 | 51 | 0.230 |
Why?
|
| Treatment Outcome | 10 | 2024 | 34238 | 0.230 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.220 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 6 | 0.220 |
Why?
|
| Heart Conduction System | 1 | 2024 | 169 | 0.220 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 71 | 0.220 |
Why?
|
| Adult | 14 | 2024 | 80709 | 0.210 |
Why?
|
| Sotalol | 2 | 2022 | 34 | 0.210 |
Why?
|
| Young Adult | 6 | 2024 | 22140 | 0.210 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 24 | 0.200 |
Why?
|
| Hospitalization | 3 | 2022 | 2217 | 0.190 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 9 | 0.180 |
Why?
|
| Warfarin | 1 | 2022 | 159 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 559 | 0.180 |
Why?
|
| Adenosine | 1 | 2022 | 294 | 0.170 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1219 | 0.170 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 39 | 0.170 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 129 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2024 | 39512 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 111 | 0.160 |
Why?
|
| Nasal Sprays | 1 | 2018 | 10 | 0.160 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 76 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 2024 | 896 | 0.160 |
Why?
|
| Exercise Test | 1 | 2019 | 316 | 0.160 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 326 | 0.160 |
Why?
|
| Syncope | 1 | 2018 | 65 | 0.160 |
Why?
|
| Male | 13 | 2024 | 127630 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 135 | 0.160 |
Why?
|
| Rivaroxaban | 1 | 2018 | 61 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 456 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2018 | 101 | 0.150 |
Why?
|
| Stents | 3 | 2020 | 1152 | 0.140 |
Why?
|
| Dyspnea | 1 | 2020 | 425 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2018 | 191 | 0.140 |
Why?
|
| Incidence | 3 | 2019 | 5904 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2022 | 649 | 0.140 |
Why?
|
| Time Factors | 4 | 2024 | 13266 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 270 | 0.130 |
Why?
|
| Risk Factors | 4 | 2019 | 18267 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 249 | 0.130 |
Why?
|
| Pericardiocentesis | 1 | 2015 | 35 | 0.130 |
Why?
|
| Female | 14 | 2024 | 147292 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 421 | 0.120 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 230 | 0.120 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2014 | 54 | 0.120 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 46 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 5031 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 138 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2014 | 128 | 0.110 |
Why?
|
| Athletes | 1 | 2013 | 75 | 0.110 |
Why?
|
| Pregnancy | 2 | 2018 | 7825 | 0.100 |
Why?
|
| Transducers, Pressure | 1 | 2012 | 18 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 790 | 0.100 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 18 | 0.100 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 50 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 110 | 0.100 |
Why?
|
| Heart Atria | 1 | 2014 | 367 | 0.100 |
Why?
|
| Arterial Pressure | 1 | 2012 | 107 | 0.100 |
Why?
|
| Adolescent | 4 | 2022 | 32336 | 0.090 |
Why?
|
| United States | 4 | 2018 | 16339 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 637 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2012 | 258 | 0.080 |
Why?
|
| Echocardiography | 1 | 2015 | 1262 | 0.080 |
Why?
|
| Ischemia | 1 | 2012 | 400 | 0.080 |
Why?
|
| Middle Aged | 6 | 2023 | 89535 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2012 | 1005 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 12451 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 1094 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 1348 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 5123 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5838 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 1211 | 0.060 |
Why?
|
| Aged | 5 | 2022 | 72902 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 4862 | 0.050 |
Why?
|
| Age Factors | 1 | 2011 | 5506 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 2495 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 13818 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 5030 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 30813 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7738 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2012 | 7170 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 15198 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2018 | 69 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 22249 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 254 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7962 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1382 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 185 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2017 | 199 | 0.040 |
Why?
|
| Length of Stay | 1 | 2022 | 2036 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 2319 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 80 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 50 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 470 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 444 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2662 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2019 | 16792 | 0.030 |
Why?
|
| Mesenteric Ischemia | 1 | 2012 | 13 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 72 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 451 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 324 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 185 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 9487 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 431 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 6460 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 818 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 1232 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2868 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6245 | 0.020 |
Why?
|
| Child | 2 | 2019 | 30200 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 1944 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 1106 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 2117 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 13310 | 0.020 |
Why?
|